Filing Details

Accession Number:
0000950170-23-042536
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-14 17:10:56
Reporting Period:
2023-08-11
Accepted Time:
2023-08-14 17:10:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1808898 Benitec Biopharma Inc. BNTC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1209726 Kevin J Buchi C/O Benitec Biopharma Inc.
3940 Trust Way
Hayward CA 94545
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-08-11 51,813 $0.00 52,097 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Warrants (right to buy) Acquisiton 2023-08-11 51,813 $0.00 51,813 $3.86
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
51,813 2023-08-11 2028-08-11 No 4 P Direct
Footnotes
  1. Represents shares of common stock, par value $0.0001 per share (the "Common Stock") purchased together with common warrants to purchase shares of Common Stock in the Issuer's registered underwritten offering on August 11, 2023 for a purchase price of $1.93.
  2. The reported number of shares has been adjusted to reflect the impact of the Issuer's 17-for-1 reverse stock split completed on July 26, 2023.